Plasma Exchange and Glucocorticoids for Treatment of Anti-Neutrophil Cytoplasm Antibody (ANCA) - Associated Vasculitis
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- David Jayne, MD
Cambridge University Hospitals NHS Foundation Trust
Principal Investigator - Michael Walsh, MD
McMaster University
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
98 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Canberra Hospital
Garran, Australian Capital Territory, Australia
- Concord Repatriation General Hospital
Concord, New South Wales, Australia
- John Hunter Hospital,
New Lambton Heights, New South Wales, Australia
- Prince of Wales Hospital
Randwick, New South Wales, Australia
- Royal North Shore Hospital
St Leonards, New South Wales, Australia
- Royal Brisbane and Women'S Hospital
Herston, Queensland, Australia
- Nambour Hospital
Nambour, Queensland, Australia
- Princess Alexandra Hospital
Woolloongabba, Queensland, Australia
- Flinders Medical Centre,
Adelaide, South Australia, Australia
- Royal Adelaide Hospital
Adelaide, South Australia, Australia
- Royal Hobart Hospital
Hobart, Tasmania, Australia
- Monash Medical Centre
Clayton, Victoria, Australia
- St Vincent'S Hospital
Fitzroy, Victoria, Australia
- the Geelong Hospital
Geelong, Victoria, Australia
- Austin Hospital
Heidelberg, Victoria, Australia
- the Royal Melbourne Hospital
Parkville, Victoria, Australia
- Fremantle Hospital,
Fremantle, Western Australia, Australia
- Gold Coast Hospital
Southport, Australia
- University Hospitals Leuven
Leuven, Belgium
- University of Calgary
Calgary, Alberta, Canada
- University of Alberta
Edmonton, Alberta, Canada
- St Paul'S Hospital
Vancouver, British Columbia, Canada
- St Joseph'S Hospital
Hamilton, Ontario, Canada
- London Health Sciences Centre
London, Ontario, Canada
- the Ottawa Hospital
Ottawa, Ontario, Canada
- Mount Sinai Hospital
Toronto, Ontario, Canada
- St Michael'S Hospital
Toronto, Ontario, Canada
- Hopital Saint-Luc
Montreal, Quebec, Canada
- General Faculty Hospital
Prague, Czechia
- Aarhus University Hospital
Aarhus, Denmark
- Herlev Hospital
Copenhagen, Denmark
- Rigshospitalet
Copenhagen, Denmark
- Holstebro Hospital and University of Aarhus
Holstebro, Denmark
- Centre Hospitalier de Boulogne
Boulogne-sur-Mer, France
- Chru Brest Hopital la Cavale Blanche
Brest, France
- Chu Brest
Brest, France
- Chu Caen - Nephrology Department
Caen, France
- Chu Clermont-Ferrand
Clermont-Ferrand, France
- Colmar Hospital - Nephrology
Colmar, France
- Chu D'Angers
D'Angers, France
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 May 2010
- Primary completion
- 31 Aug 2017
- Completion
- 31 Aug 2017
- Last update posted
- 26 May 2020
- Registered enrollment
- 704
- Registry id
- NCT00987389
Cross-registrations
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.